NeurologyLive® Friday 5 — January 3, 2024

Author(s):

Key Takeaways

Sleep disorders and Alzheimer’s disease saw significant advancements and paradigm shifts in 2024.
Neuromuscular disorders experienced rapid progress, especially in genetic medicine, over the past two years.
Insights from the International Journal of Multiple Sclerosis Care highlighted research and community contributions.
Multiple sclerosis diagnostics are transitioning from rigid classifications to a spectrum-based approach focused on biological phenotyping.

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 3, 2024.

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: NeurologyLive® Year in Review 2024: Top Stories in Sleep Disorders

In 2024, the NeurologyLive® team worked tirelessly to deliver the latest clinical news and data across a wide range of neurology subspecialties. A major area of focus was sleep disorders, a field that continues to see significant advancements.

2: NeurologyLive® Year in Review 2024: Top Stories in Alzheimer Disease and Dementia

In 2024, the NeurologyLive^® staff was a busy bunch, covering clinical news and data readouts from around the world across a number of key neurology subspecialty areas. Among our key focus areas is Alzheimer disease and dementia, a field that experienced massive shifts in the therapeutic paradigm in the past 12 months, among other progress.

3: NeurologyLive® Year in Review 2024: Top Stories in Neuromuscular Disorders

The NeurologyLive^® staff was hard at work in 2024, covering clinical news and data readouts from all over the United States and beyond, across a number of key neurology subspecialty areas. Among our key focus areas is neuromuscular disorders, a field that has experienced perhaps its most rapid period of progress in the past 2 years, with large steps forward in genetic medicine, in particular.

4: IJMSC Insights: Ahmed Obeidat on Art and Medicine

IJMSC Insights offers a closer look at the latest research and the people behind it from the community of the International Journal of Multiple Sclerosis Care (IJMSC) and the Consortium of Multiple Sclerosis Centers (CMSC).

IJMSC Insights: Ahmed Zayed Obeidat on the Intersection of Art and Medicine

5: Evolving MS Diagnostics From Categorical Classifications to Biological Phenotyping: Fred Lublin, MD

The director of the Corinne Goldsmith Dickinson Center for MS at Mount Sinai talked about the shift in multiple sclerosis diagnostics from rigid classification systems to a dynamic, spectrum-based approach focused on biological phenotyping. [WATCH TIME: 5 minutes]